과제정보
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2015R1A2A2A01004593 and NRF-2019R1A2C1005219).
참고문헌
- Campisi J (2013) Aging, cellular senescence, and cancer. Annu Rev Physiol 75, 685-705 https://doi.org/10.1146/annurev-physiol-030212-183653
- Kuilman T, Michaloglou C, Mooi WJ and Peeper DS (2010) The essence of senescence. Genes Dev 24, 2463-2479 https://doi.org/10.1101/gad.1971610
- Dimri GP, Lee X, Basile G et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92, 9363-9367 https://doi.org/10.1073/pnas.92.20.9363
- Zhang R, Chen W and Adams PD (2007) Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol 27, 2343-2358 https://doi.org/10.1128/MCB.02019-06
- Narita M, Nunez S, Heard E et al (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716 https://doi.org/10.1016/S0092-8674(03)00401-X
- Kouzarides T (2007) Chromatin modifications and their function. Cell 128, 693-705 https://doi.org/10.1016/j.cell.2007.02.005
- Ait-Si-Ali S, Guasconi V, Fritsch L et al (2004) A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J 23, 605-615 https://doi.org/10.1038/sj.emboj.7600074
- Whetstine JR, Nottke A, Lan F et al (2006) Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125, 467-481 https://doi.org/10.1016/j.cell.2006.03.028
- Couture JF, Collazo E, Ortiz-Tello PA et al (2007) Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase. Nat Struct Mol Biol 14, 689-695 https://doi.org/10.1038/nsmb1273
- Gray SG, Iglesias AH, Lizcano F et al (2005) Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. J Biol Chem 280, 28507-28518 https://doi.org/10.1074/jbc.M413687200
- Shi Y, Lan F, Matson C et al (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953 https://doi.org/10.1016/j.cell.2004.12.012
- Wissmann M, Yin N, Muller JM et al (2007) Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat Cell Biol 9, 347-353 https://doi.org/10.1038/ncb1546
- Berry WL and Janknecht R (2013) KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res 73, 2936-2942 https://doi.org/10.1158/0008-5472.CAN-12-4300
- Huang J, Sengupta R, Espejo AB et al (2007) p53 is regulated by the lysine demethylase LSD1. Nature 449, 105-108 https://doi.org/10.1038/nature06092
- Johmura Y, Sun J, Kitagawa K et al (2016) SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence. Nat Commun 7, 10574 https://doi.org/10.1038/ncomms10574
- Wullschleger S, Loewith R and Hall MN (2006) TOR signaling in growth and metabolism. Cell 124, 471-484 https://doi.org/10.1016/j.cell.2006.01.016
- Morita M, Gravel SP, Hulea L et al (2015) mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle 14, 473-480 https://doi.org/10.4161/15384101.2014.991572
- Ryu SW, Woo JH, Kim YH et al (2006) Downregulation of protein kinase CKII is associated with cellular senescence. FEBS Lett 580, 988-994 https://doi.org/10.1016/j.febslet.2006.01.028
- Kang JY, Kim JJ, Jang SY and Bae YS (2009) The p53-p21Cip1/WAF1 pathway is necessary for cellular senescence induced by the inhibition of protein kinase CKII in human colon cancer cells. Mol Cells 28, 489-494 https://doi.org/10.1007/s10059-009-0141-9
- Park JH, Kim JJ and Bae YS (2013) Involvement of PI3K-AKT-mTOR pathway in protein kinase CKII inhibition-mediated senescence in human colon cancer cells. Biochem Biophys Res Commun 433, 420-425 https://doi.org/10.1016/j.bbrc.2013.02.108
- Jang DE, Song J, Park JW, Yoon SH and Bae YS (2020) Protein kinase CK2 activates Nrf2 via autophagic degradation of Keap1 and activation of AMPK in human cancer cells. BMB Rep 53, 272-277 https://doi.org/10.5483/BMBRep.2020.53.5.044
- Park JH, Lee JH, Park JW et al (2017) Downregulation of protein kinase CK2 activity induces age-related biomarkers in C. elegans. Oncotarget 8, 36950-36963 https://doi.org/10.18632/oncotarget.16939
- Park JW, Kim JJ and Bae YS (2018) CK2 downregulation induces senescence-associated heterochromatic foci formation through activating SUV39h1 and inactivating G9a. Biochem Biophys Res Commun 505, 67-73 https://doi.org/10.1016/j.bbrc.2018.09.099
- Wei J, Ma L, Lai YH et al (2019) Bazedoxifene as a novel GP130 inhibitor for colon cancer therapy. J Exp Clin Cancer Res 38, 63 https://doi.org/10.1186/s13046-019-1072-8
- Park JW and Bae YS (2019) Dephosphorylation of p53 Ser392 enhances trimethylation of histone H3 Lys9 via SUV39h1 stabilization in CK2 downregulation-mediated senescence. Mol Cells 42, 773-782 https://doi.org/10.14348/molcells.2019.0018
- Morera L, Lubbert M and Jung M (2016) Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy. Clin Epigenetics 8, 57 https://doi.org/10.1186/s13148-016-0223-4
- Monaghan L, Massett ME, Bunschoten RP et al (2019) The emerging role of H3K9me3 as a potential therapeutic target in acute myeloid leukemia. Front Oncol 9, 705 https://doi.org/10.3389/fonc.2019.00705
- Fiskus W, Sharma S, Shah B et al (2014) Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells. Leukemia 28, 2155-2164 https://doi.org/10.1038/leu.2014.119